Clinical insights into the diagnosis and management of renovascular disease: An evidence-based review

Minerva Medica

Volumn 95, Issue 5, 2004, Pages 357-373

  Bloch, M J ^a   Basile, J ^b,c  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cardiovascular diaseses, therapy; Cardiovascular disease, diagnosis; Kidney diseases, diagnosis; Kidney diseases, therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CAPTOPRIL; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KIDNEY RENIN;

ACUTE KIDNEY FAILURE; ALGORITHM; ANGIOGRAPHY; ATHEROSCLEROSIS; BLEEDING; BLOOD PRESSURE REGULATION; CAPTOPRIL PLASMA RENIN TEST; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY ANGIOGRAPHY; CONTRAST ENHANCEMENT; DIGITAL SUBTRACTION ANGIOGRAPHY; DIPEPTIDYL CARBOXYLASE INHIBITOR AUGMENTED SCINTIGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; EMBOLISM; FALSE ANEURYSM; FIBROMUSCULAR DYSPLASIA; FUNCTION TEST; HEART INFARCTION; HEMATOMA; HUMAN; ISCHEMIC NEPHROPATHY; KIDNEY ARTERY STENOSIS; KIDNEY DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL DECISION MAKING; META ANALYSIS; NON INVASIVE MEASUREMENT; PERCUTANEOUS INTERVENTION; PLASMA RENIN ACTIVITY; POSTOPERATIVE COMPLICATION; RENAL ARTERY DISSECTION; RENOVASCULAR DISEASE; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; SMOKING CESSATION; STENT; SYSTEMATIC REVIEW; THROMBOSIS;

AGED; ALGORITHMS; ANGIOGRAPHY; ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY, BALLOON; ARTERIOSCLEROSIS; FEMALE; FIBROMUSCULAR DYSPLASIA; HUMANS; HYPERTENSION, RENOVASCULAR; ISCHEMIA; KIDNEY; KIDNEY DISEASES; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RENAL ARTERY OBSTRUCTION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STENTS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 8344241963     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Olin JW, Melia M, Young JR, Graor RA, Risius B. Prevalence of atherosclerotic RAS in patients with atherosclerosis elsewhere. Am J Med 1990;88:46N-51N.
2. Greco BA, Breyer JA. Atheroscleotic ischemic renal disease. Am J Kid Dis 1997;29:167-87.
3. vanAmpting JM, Penne EL, Beek FJ, Koomans HA, Boer WH, Beutler JJ. Prevalence of atherosclerotic renal artery stenosis in patients starting dialysis. Nephrol Dial Transplant 2003;18:1147-51.
4. Kohlhagen J, Kelly J. Prevalence of vascular risk factors and vascular disease in predialysis chronic renal failure. Nephrology 2003;8:274-9.
5. Holley KE, Hunt JC, Brown AL Jr. Renal artery stenosis. A clinical-pathological study in normotensive and hypertensive patients. Am J Med 1964;37:124-32.
6. Buller CE, Nogareda JG, Ramanathan K, Ricci DR, Djurdjev O, Tinckam KJ et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 2004;43:1606-13.
7. Aqel RA, Zoghbi GJ, Baldwin SA, Auda WS, Calhoun DA, Coffey CS et al. Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization. J Hypertens 2003;21:1157-63.
8. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in 't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998;129;705-11.
9. Ailawadi G, Stanley JC, Williams DM, Dimick JB, Henke PK, Upchurch GR Jr. Gadolinium as a nonnephrotoxic contrast agent for catheter-based arteriographic evaluation of renal arteries in patients with azotemia. J Vasc Surg 2003;37:346-52.
10. Sealey JE, James GD, Laragh JH. Interpretation and guidelines for the use of plasma and urine aldosterone and plasma angiotensin II, angiotensinogen, prorenin, peripheral and renal vein rennin tests. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management. New York: Raven Press; 1995.p.1953-68.
11. Wilcox CS. Functional testing: renin studies. Semin Nephrol 2000;20:432-6.
12. Muller FB, Sealey JE, Case CB, Atlas SA, Pickering TG, Pecker M et al. The captopril test for identifying renovascular disease in hypertensive patients. Am J Med 1986;80:633-44.
13. Vaughan ED, Buhler FR, Laragh JH, Sealey JE, Baer L, Bard RH. Renovascular hypertension: renin measurements to indicate hypersecretion and contralateral suppression, estimate renal plasma flow, and score for surgical curability. Am J Med 1973;55:402-14.
14. VanJaarsveld BC, Krijnen P, Derkx FH, Oei HY, Postma M, Schalekamp MA. The place of renal scintigraphy in the diagnosis of renal artery stenosis: fifteen years of clinical experience. Arch Intern Med 1997;157:1226-34.
15. Setaro JF, Saddler MC, Chen CC, Hoffer PB, Roer DA, Markowitz DM et al. Simplified captopril renography in diagnosis and treatment of renal artery stenosis. Hypertension 1991;18:289-98.
16. Taylor A, Nally J, Aurell M, Blaufox D, Dondi M, Dubovsky E et al. Consensus report on ACE-inhibitor renography for detecting renovascular hypertension: radionucleotides in nephrology group: Consensus Group on ACEI Renography. J Nucl Med 1996;37:1876-82.
17. Fommei E, Ghione S, Hilson AJ, Mezzasalma L, Oei HY, Piepsz A et al. Captopril radionuclide test in renovascular hypertension: European Multicentre Study Group. Eur J Nucl Med 1993;20:617-23.
18. Taylor A. Functional testing: ACEI renography. Semin Nephol 2000;20:437-44.
19. Geyskes GG, De Bruyn AJG. Captopril renography and the effect of percutaneous transluminal angioplasty on blood pressure in 94 patients with renal artery stenosis. Am J Hypertens 1991;4:6855-95.
20. Mann SJ, Pickering TG, Sos TA, Uzzo RG, Sarkar S, Friend K et al. Captopril renography in the diagnosis of renal artery stenosis: accuracy and limitations. Am J Med 1991;90:30-40.
21. Strandness DE. Doppler and ultrasound methods for diagnosis. Semin Nephrol 2000;20:445-9.
22. Hoffmann U, Edwards JM, Carter S, Goldman ML, Harley JD, Zaccardi MJ et al. Role of duplex scanning for the detection of atherosclerotic renal artery disease. Kidney Int 1991;31:1232-9.
23. Hansen KJ, Tribble RW, Reavis, Canzanello VJ, Craven TE, Plonk GW Jr et al. Renal duplex sonography: evaluation of clinical utility. J Vasc Surg 1990;12:227-36.
24. Taylor DC, Kettler MD, Moneta GL, Kohler TR, Kazmers A, Beach KW et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: a prospective evaluation. J Vasc Surg 1988;7:363-9.
25. Olin JW, Piedmonte MA, Young JR, DeAnna S, Grubb M, Childs MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. Ann Intern Med 1995;122:833-8.
26. Halpern EJ, Needleman L, Nack TL, East SA. Renal artery stenosis: should we study the main renal artery or segmental vessels? Radiology 1995;195:799-804.
27. Nazzal MMS, Hoballah JJ, Miller EV, Sharp WJ, Kresowik TF, Corson JD. Renal hilar doppler analysis is of value in the management of patients with renovascular disease. Am J Surg 1997;174:164-8.
28. Johansson M, Jensen G, Aurell M, Friberg P, Herlitz H, Klingenstierna H et al. Evaluation of duplex ultrasound and captopril renography for detection of renovascular hypertension. Kidney Int 2000;58:774-82.
29. Motew SJ, Cherr GS, Craven TE, Travis JA, Won JM, Reavis SW et al. Renal duplex sonography: main renal artery versus hilar analysis. J Vasc Surg 2000;32:462-71.
30. Demirpolat G, Ozbeck SS, Parildar M, Oran I, Memis A. Reliability of intrarenal Doppler sonographic parameters of renal artery stenosis. J Clin Ultrasound 2003;31:346-51.
31. Blebea J, Zickler R, Volteas N, Neumyer M, Assadnia S, Anderson K et al. Duplex imaging of the renal arteries with contrast enhancement. Vasc Endovascular Surg 2003;37:429-36.
32. Manganaro A, Andò G, Salvo A, Consolo A, Coppolino F, Giannino D. A comparison of power Doppler with conventional sonographic imaging for the evaluation of renal artery stenosis. Cardiovasc Ultrasound 2004;2:1.
33. Radermacher J, Chavan A, Bleek J, Vitzthum A, Stoess B, Gebel MJ et al. Use of Doppler ultrasonography to predict the outcome of therapy in renal artery stenosis. N Engl J Med 2001;344:410-7.
34. Gandy SJ, Sudarshan TA, Sheppard DG, Allan LC, McLeay TB, Houston JG. Dynamic MRI contrast enhancement of renal cortex: a functional assessment of renovascular disease in patients with renal artery stenosis. J Magn Reson Imaging 2003;18:461-6.
35. Montet X, Ivancevic MK, Belenger J, Jorge-Costa M, Pochon S, Pechere A et al. Noninvasive measurement of absolute renal perfusion by contrast medium enhanced magnetic resonance imaging. Invest Radiol 2003;38:584-92.
36. Yim PJ, Cebral JR, Weaver A, Lutz RJ, Soto O, Vasbinder GB et al. Estimation of the differential pressure at renal artery stenosis. Magn Reson Med 2004;51:969-77.
37. Vasbinder GBC, Nelemans PJ, Kessels AGH, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med 2001;135:401-11.
38. DeCobelli E, Vanzuli A, Sironi S, Mellone R, Angeli E, Venturini M et al. Renal artery stenosis: evaluation with breath-hold, three-dimensional, dynamic, gadolinium-enhanced versus three-dimensional, phase-contrast MR angiography. Radiology 1997;205:689-95.
39. Rieumont MJ, Kaufman JA, Geller SC, Yucel EK, Cambria RP, Fang LS et al. Evaluation of renal artery stenosis with dynamic gadolinium enhanced MR angiography. Am J Roentgenol 1997;169:39-44.
40. Holland GA, Dougherty L, Carpenter JP, Golden MA, Gilfeather M, Slossmen F et al. Breath hold ultrafast three dimensional gadolinium enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries. Am J Roentgenol 1996;166:971-81.
41. Prince MR, Schoenberg SO, Ward JS, Londy FJ, Wakefield TW, Stanley JC. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology 1997;205:128-36.
42. Fain SB, King BF, Breen JF, Kruger DG, Riederer SJ. High-spacial resolution contast-enhanced MR angiography of the renal arteries: a prospective comparison with digital subtraction angiography. Radiology 2001;218:481-90.
43. Beregi JP, Elkohen M, Deklunder G, Artaud D, Coullet JM, Wattinne L. Helical CT angiography compared with arteriography in the detection of renal artery stenosis. Am J Roentgenol 1996;167:495-501.
44. Olbricht CJ, Prokop M, Chavan A, Chavan A, Schaefer-Prokop CM, Jandeleit K et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int 1995;48:1332-7.
45. Kaatee R, Beek FJ, de Lange EE, van Leeuwen MS, Smits HF, van der Yen PJ et al. Renal artery stenosis: detection and quantification with spiral CT angiography versus optimized digital subtraction angiography. Radiology 1997;205:121-7.
46. Farres MT, Lammer J, Schima W, Wagner B, Wildling R, Winkelbauer F et al. Spiral computed tomographic angiography of the renal arteries: a prospective comparison with intravenous and intra-arterial digital subtraction angiography. Cardiovasc Interv Radiol 1996;19:101-6.
47. Leung DA, Hoffmann U, Pfammatter T, Hany TF, Rainoni L, Hilfiker P et al. Magnetic resonance angiography versus duplex sonography for diagnosing renovascular disease. Hypertension 1999;33:726-9.
48. Attallah N, Yee J, Gutierrez A, Musial J, Parasuramen R. Likelihood ratios in the diagnosis of renal artery stenosis by magnetic resonance angiography compared with renal angiography. Am J Hypertens 2003;16:987-92.
49. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med 2001;344:431-42.
50. Rundback JH, Sacks, D, Kent KC, Cooper C, Jones D, Murphy T et al. Guidelines for the reporting of renal artery revascularization in clinical trials. J Vasc Interv Radiol 2003;14:S477-92.
51. Novick AC. Options for therapy of ischemic nephropathy. Role of angioplasty and surgery. Semin Nephrol 1996;16:53-60.
52. Franklin SS, Young JD Jr, Maxwell MH. Operative morbidity and mortality in renovascular disease. JAMA 1975;231:1148-53.
53. Cambia RP, Brewster DC, L'Italien G. Simultaneous aortic and renal artery reconstruction: evolution of an eighteen year experience. J Vasc Surg 1995;21:916-25.
54. Steinbach F, Novick AC, Campbell S, Dykstra D. Long-term survival after surgical revascularization for atherosclerotic renal artery disease. J Urol 1997;158:38-41.
55. Libertino JA, Bosco PJ, Ting CY. Renal revascularization to preserve and restore renal function. J Urol 1982;145:1485-7.
56. Hansen JF, Starr SM, Sands RE. Contemporary surgical management of renovascular disease. Urol Clin North Am 1984;11:435-49.
57. Hallett JW, Fowl R, O'Brien PC. Renovascular operations in patients with chronic renal insufficiency: do the benefits justify the risks? J Vasc Surg 1987;5:622-7.
58. Marone LK, Clouse WD, Dorer DJ, Brewster DC, Lamuraglia GM, Watkins MT et al. Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease. J Vasc Surg 2004;39:322-9.
59. Marekovic Z, Mokos I, Krhen I, Goreta NR, Roncevic T. Long-term outcome after surgical kidney revascularization for fibromuscular dysplasia and atherosclerotic renal artery stenosis. J Urol 2004;18:1043-5.
60. Weibull H, Bergqvist D, Bergentz SE, Jonsson K, Hulthen L, Manhem P. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993;18:841-50.
61. Erdoes LS, Berman SS, Hunter GC, Mills JL. Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularization. Am J Kidney Dis 1996;27:496-503.
62. Alhadad A, Ahle M, Ivancev K, Gottsater A, Linblad B. Percutaneous transluminal renal angioplasty (PTRA) and surgical revascularization in renovascular disease: a retrospective comparison of results, complications and mortality. Eur J Vasc Endovasc Surg 2004;27:151-6.
63. Sos TA, Pickering TG, Sniderman K, Saddekni S, Case CB, Silane MF et al. Percutaneous transluminal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med 1983;309:274-9.
64. Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc 1995;70:1041-52.
65. Libertino JA, Beckmann CF. Surgery and percutaneous angioplasty in the management of renovascular hypertension. Urol Clin N Am 1994;21:235-43.
66. Cluzel P, Raynaud A, Beyssen B, Pagny JY, Gaux JC. Stenosis of renal branch arteries in fibromuscular dysplasia: results of percutaneous transluminal angioplasty. Radiology 1994;193:227-32.
67. Surowiec SM, Sivamurthy N, Rhodes JM, Lee De, Walman DL, Green RM et al. Percutaneous therapy for renal artery fibromuscular dysplasia. Ann Vasc Surg 2003;17:650-5.
68. Sivamurthy N, Surowiec SM, Cluakova E, Rhodes JM, Lee D, Sternbach Y et al. Divergent outcomes after percutaneous therapy for symptomatic renal artery stenosis. J Vasc Surg 2004;39:565-74.
69. Rees CR, Palmaz JC, Becker GJ, Ehrman KO, Richter GM, Noeldge G et al. Palmaz stent in atherosclerotic stenosis involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology 1991;181:507-14.
70. Hennequin LM, Joffre FG, Rousseau HP, Azizu R. Tregant P, Bernadet P et al. Renal artery stent placement. Long term results with the wallstent endoprosthesis. Radiology 1994;191:713-9.
71. Raynaud AC, Beyssen BM, Turmel-Rodigues LE, Pagny JY, Sapoval MR, Gaux JC et al. Renal artery stent placement: intermediate and mid-term results. J Vasc Surg Intervent Radiol 1994;5:849-58.
72. van de Ven PJG, Beutler JJ, Daatee R, Beek FJ, Mali WP, Geyskes GG et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet 1995;346:672-4.
73. Iannone LA, Underwood PL, Nath A, Tannenbaum MA, Ghali MG, Clevenger LD et al. Effect of primary balloon expandable renal artery stents on long-term patency, renal function and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn 1990;37:243-50.
74. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K et al. Four year follow-up of palmaz-shatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-7.
75. Blum U, Flugel P, Gabelmann A, Gabelmann A, Lehnert T, Buitrago-Tellez C et al. Treatment of ostial renal artery stenoses with vascular endoprosthesis after unsuccessful balloon angioplasty. N Engl J Med 1997;337:459-65.
76. Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR, Short RA, Henneberry KJ et al. Treatment of atherosclerotic ostial renal artery stenosis with intravascular stent. Am J Kidney Dis 1998;32:611-22.
77. Gill KS, Fowler RC. Atherosclerotic renal artery stenosis: clinical outcomes of stent placement for hypertension and renal failure. Radiology 2003;226:821-6.
78. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Horn B et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004;11:95-106.
79. Canzanello VJ, Millan VG, Spiegel JE, Ponce PS, Kopelman RI, Madias NE. Percutaneous renal angioplasty in the management of atherosclerotic renovascular hypertension: results in 100 patients. Hypertens 1989;13:163-72.
80. Martin LG, Casarella WJ, Gaylord GM. Azotemia caused by renal artery stenosis: treatment by percutaneous angioplasty. Am J Roentgenol 1988;150:839-44.
81. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000;102:1671-7.
82. Zeller T, Frank U, Muller C, Bugelin K, Sinn L, Besthorn HP et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003;108:2244-9.
83. Taylor A, Sheppard D, MacLeod MJ. Renal artery stent placement in renal artery stenosis: technical and early clinical results. Clin Radiol 1997;52:451-7.
84. Slonim SM, Dake MD. Radiographic evaluation and treatment of renovascular disease. In: Rutherford RB, editor. Vascular surgery. Philadelphia: W. B. Saunders Company; 2000.p.1611-39.
85. Korsakas S, Mohaupt MG, Dinkel HP, Mahler F, Do DD, Voegele J et al. Delay of dialysis in end-stage renal failure: prospective study on percutaneous renal artery intervention. Kidney Int 2004;65:251-8.
86. Ivanovic V, McKusick MA, Johnson CM, Sabater EA, Andrews JC, Breen JF et al. Renal artery stent placement: complications at a single tertiary care center. J Vasc Interv Radiol 2003;14:217-25.
87. Bloch MJ, Trost DW, Sos TA, Pickering TG, August P. Renal artery stent placement in patients seventy-five years of age or older. Am J Hypertens 2001;14:983-8.
88. Zeller T, Frank U, Muller C, Burgelin K, Schwarzwalder U, Sinn L et al. Technological advances in the design of catheters and devices used in renal artery interventions: impact on complications. J Endovasc Ther 2003;10:1006-114.
89. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg 2003;38:962-8.
90. Dorros G, Jaff M, Mathiak L, He T, Minor R, Harner R et al. Renal function and survival after renal artery stent revascularization may be influenced by embolic debris. J Invasive Cardiol 2004;16:189-95.
91. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G et al. Renal angioplasty and stenting under protection: the way for the future. Catheter Cardiovasc Interv 2003;60:299-312.
92. National Cholesterol Education Program. Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final Report. Bethesda: National Cholesterol Education Program. National Heart, Lung and Blood Institute; National Institutes of Health, NIH Publication No. 02-5215, September 2002.
93. Hollenberg NK. Medical therapy of renovascular hypertension: efficacy and safety of captopril in 269 patients. Cardiovasc Rev Rep 1983;4:852-76.
94. Franklin SS, Smith RD. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am J Med 1985;79:14-23.
95. Textor SC. Renal failure related to ACE inhibitors. Semin Nephrol 1997;17:67-76.
96. Jackson B, Matthews PG, McGrath BP, Johnston CI. Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Lancet 1984;28:225-6.
97. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
98. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG et al. Randomized comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Human Hypertens 1998;12:329-35.
99. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998;31:823-9.
100. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000;342:1007-14.
101. Nordmann AJ, Woo K, Parkes R, Logan AG. Balloon angioplasty or medical therapy or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med 2003;114:44-50.
102. Novick AC. Atherosclerotic ischemic nephropathy: epidemiology and clinical considerations. Urol Clin North Am 1994;21:195-200.
103. Stewart BH, Dustan HP, Kiser WS, Meaney TF, Straffon RA, McCormack LJ. Correlation of angiography and natural history in evaluation of patients with renovascular hypertension. J Urol 1970;104:231-8.
104. Tollefson DE, Ernst CB. Natural history of atherosclerotic renal artery stenosis associated with aortic disease. J Vasc Surg 1991;14:327-31.
105. Dean RH, Kieffer RW, Smith BM, Oates JA, Nadeau JH, Hollifield JW et al. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg 1981;116:1408-15.
106. Schreiber MF, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984;11:383-92.
107. Caps MT, Zierler E, Polissar NL, Polissar NL, Bergelin RO, Tullis MJ et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998;53:735-42.
108. Leertouwer TC, Pattynama PMT, Van Den Berg-Hysmans A. Incidental renal artery stenosis in peripheral vascular disease: a case for treatment? Kidney Int 2000;59:1480-3.
109. Textor SC. Epidemiology and clinical presentation. Semin Nephrol 2000;20:426-31.